HCPLive Podcasts

Sarcoidosis is a systemic inflammatory disease of unknown origin that is categorized by the formulation of granulomas in various parts of the body including the lungs, skin, heart, and brain. Though the disease does not always require medication, careful monitoring and management is always recommended as it may present in fatigue, pain, small fiber neuropathy and other comorbidities. Sarcoidosis i...

Our first episode back features Karen Kozarsky, PhD, an expert on gene therapy and adrenomyeloneuropathy (AMN). She has an in-depth discussion with our new host Giuliana Grossi about what the future might hold for AMN treatment.

At HCPLive , we’ve had the incredible privilege of speaking with doctors from a variety of different clinical fields as well as different cultural, racial, and ethnic backgrounds. Without their dedication, insights, and generosity, the health care system and the world at large would be at a loss.  Even publications such as our own benefit from their work in a myriad of ways. In this episode of Doc...

Rheumatology Network interviewed Terence Rooney, MD, to discuss the findings of a Network Meta-Analysis that examined the efficacy of guselkumab (TREMFYA) for skin clearance and joint improvements in patients with psoriatic arthritis.

Across all areas of study in health care and especially in recent years, African American patients and physicians have experienced racial inequity regarding telemedicine practices across the US.  However, a new pilot trial from the Perelman School of Medicine at the University of Pennsylvania suggested  subtle modifications in the methods of virtually engaging with Black patients that could be use...

In early February, the American College of Rheumatology (ACR) announced an updated version of its COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and Musculoskeletal Diseases. This update - the fifth of its kind- featured support for booster and supplemental doses in addition to recommendations regarding the timing of the injection as well as immunomodulatory medication use. Revisio...

In this episode of DocTalk, we interview Janae Sharp, founder of the Sharp index, on some of these larger, slightly philosophical questions surrounding physician burnout, including how to measure and define success, as well as the deeper layers of stigma that must be addressed as part of the process.

Though sickle cell disease had been present in Africa for over 5000 years, it was first “discovered” in 1910 when a dental student named Walter Clement Noel became the first patient to be formally diagnosed. From there, more would be uncovered about the disease in the decades following his diagnosis, such as how it disproportionately affects patients of African descent. According to the Centers fo...

In late January, a team of investigators from the Centers for Disease Control and Prevention (CDC) reported findings from the Vaccine Adverse Event Reporting System (VAERS) indicating a significantly low risk of myocarditis following vaccination with either available messenger RNA (mRNA) vaccine for COVID-19 in persons aged 24 years and younger. Cases of the inflammatory heart event occurred 1626...

Today marks the fourth-ever National Women Physicians Day, an event that that is intended to pay respect to women physicians across the country. It’s held each year on Elizabeth Blackwell's birthday, who was the first female medical doctor in the United States.   Though much has changed since then, there are still fewer female doctors nationally than male doctors, an issue often caused by gender i...

Last week, Janssen announced results from a network meta-analysis (NMA) that showed that the biologic therapy guselkumab ranked highest for overall level of skin clearance. The NMA involved 33 phase 3 randomized clinical trials and 15 different targeted therapies including risakinumab and more. Philip J. Mease, MD, director of rheumatology research at the Swedish Rheumatology Research Group, spoke...

Prior to the COVID-19 pandemic, the subject of physician burnout was likely not considered or completely understood by large swaths of the American public. Despite this, burnout has been an issue that has plagued physicians for decades prior to the pandemic, and the consequences of it are far-reaching. In an interview for the latest installment of Crisis Point with Connor Iapoce, Dr. Lakshmana Swa...

In mid-January, Mount Sinai Health System and Icahn School of Medicine announced the launch of the Institute for Airway Sciences (IAS) , a multidisciplinary institute intended to establish new therapies for patients with sinus, laryngotracheal airway, and lung diseases. The institute will be opened under the guidance of Eric Genden, MD, MBA, Professor and System Chair of Otalaryngology, who spoke...

In January, The American Red Cross reported that it was facing “its worst blood shortage in over a decade” amid surging cases of the Omicron variant of the COVID-19 virus. For the first time since its inception, the Red Cross declared a “Blood Crisis”, with blood and platelet donations reaching critically low levels. Among those affected are patients with sickle cell disease. Edward Ivy, MD, MPH,...

With Chronic Obstructive Pulmonary Disease (COPD) being cited as the third leading cause of mortality globally, the data surrounding the condition has naturally continued to broaden. In high-income countries, COPD is predominantly typically linked to cigarette exposure, tobacco smoke and poor sleep habits.  However, people in low- and middle-income countries are often predisposed to a multitude of...

With the Centers for Disease Control and Prevention observing a steady increase in influenza cases early in the year, the subject of influenza vaccination has become increasingly prevalent. Keipp Talbot, MD, MPH, Associate Professor of Medicine in the Division of Infectious Diseases at Vanderbilt University, sat down with HCPLive managing editor Kevin Kunzmann to discuss the most recent vaccine in...

DocTalk returns in 2022 with a discussion of the recent Food and Drug Administration (FDA) approval of tralokinumab for the treatment of moderate-to-severe atopic dermatitis in adult patients.  For this episode, Jonathan Silverberg, MD, PhD, MPH, discusses the ECZTRA trials, 3 phase 3 trials that evaluated the efficacy of the biologic as a monotherapy as well as a combination therapy with topical...

In this Derm Discussions, Moody speaks to how the coding changes can aid in streamlining billing documentation for dermatologists.

Dr. Jellinger joins the podcast to discuss the lipid section of the DCRM Multispecialty Practice Recommendations, as well the role of combination therapies and other concepts to lower LDL and what is coming next for the field of diabetes in 2022. 

Donald Alcendor, PhD, joins to review currently available data surrounding the newest COVID-19 variant of concern, and shares guidance for concerned clinicians and the general public.

On this month's episode, we interviewed Courtney Wells, PhD, MPH, MSW, to discuss the impact of COVID-19 on the quality of life of patients with rheumatic conditions, focusing on perceived risk and decision making.

Soumya Chakravarty, MD, PhD, discusses the unmet patient needs in immune-mediated diseases as well as Janssen’s work in scientific innovation that allows patients to live their lives more unburdened by their disease. Chakravarty is the Sr Director and Strategic Lead in the Rheumatology Therapeutics area at Janssen. 

The Director of Retina Services at Wills Eye Hospital joins to discuss the historic FDA approval granted for a novel method of ophthalmic care: a permanent implant that allows for vision-saving formula therapy to treat the eye continually. Read more about the PDS approval here. Episode notes: 0:12 Intro 1:07 What is the Port Delivery System? 2:39 The history of developing the PDS 17:00 Is PDS excl...

Dr. Arianna Yanes provides insights into 7 new handouts developed by the Society for Pediatric Dermatology and how they aid nurses and teachers in creating a more inclusive setting for children with skin conditions.